The Life Sciences Report - Winter 2021

The firm is pleased to present the latest edition of The Life Sciences Report. This issue features a sampling of recent COVID-19-related client activity in which the firm has been involved, an article on life sciences venture financings in which firm clients participated in the second half of 2019 and the first half of 2020, an interview with Cyrano Therapeutics CEO Rick Geoffrion regarding the Early Feasibility Studies Program for medical device manufacturers, and an article authored by Voler Systems president Walt Maclay on common design mistakes made by medical device start-ups. In addition, the publication includes a recap of the MedTech Emerging Growth Companies 2020 Virtual Roadshow hosted by US-Japan Medtech Frontiers and the Japan Society of Northern California; an interview with Dr. Wasim Malik of Iaso Ventures, the nation's first sector-focused neuroscience and mental health venture capital firm; and a summary of other select recent life sciences client highlights.

Please see full Newsletter below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Wilson Sonsini Goodrich & Rosati | Attorney Advertising

Written by:

Wilson Sonsini Goodrich & Rosati
Contact
more
less

Wilson Sonsini Goodrich & Rosati on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.